LEADER 00871nam0-2200301---450- 001 990008237950403321 005 20051201112545.0 035 $a000823795 035 $aFED01000823795 035 $a(Aleph)000823795FED01 035 $a000823795 100 $a20051201e19681968km-y0itay50------ba 101 0 $aeng 102 $aUS 105 $ay---n----00yy 200 1 $aRoman life in the days of Cicero$esketches drawn from his letters and speeches$fby Alfred J. Church 205 $a[Ripr. facs.] 210 $aNew York$cBiblo and Tannen$d1968 215 $aXI, 291 p.$d21 cm 300 $aRist 700 1$aChurch,$bAlfred J$0499218 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990008237950403321 952 $aDDR-XXVII B 012$b2164 ddr$fDDR$m21-9530 959 $aDDR 996 $aRoman life in the days of Cicero$9737637 997 $aUNINA LEADER 01057nam a2200277 a 4500 001 991003804289707536 008 020 $a9788883051593 035 $ab1439036x-39ule_inst 040 $aDip.to di Storia, Società e Studi sull'Uomo$bita 082 0 $a152.4 245 13$aLe emozioni$h[e-book] :$bAtti del Workshop 2019 /$ca cura di Elisabetta Caroppo, Terri Mannarini, Mariano Longo e Claudia Venuleo 260 $aLecce :$bUniversità del Salento, $c2020 300 $aebook (129 p.) 500 $aIn testa al front.: Dottorato Human & Social Sciences in ricordo di Giulio Regeni, ricercatore 650 4$aEmozioni 700 $aVenuleo, Claudia 700 $aLongo, Mariano 700 $aMannarini, Terri 700 1 $aCaroppo, Elisabetta 856 40$uhttp://siba-ese.unisalento.it/index.php/emozioni/issue/current$zE-book 907 $a.b1439036x$b03-03-22$c12-05-20 912 $a991003804289707536 996 $aEmozioni$91569445 997 $aUNISALENTO 998 $adilib$b12-05-20$cm$d@ $e-$fita$git $h3$i0 LEADER 01403nas 22003973a 450 001 9910142821603321 005 20240413014407.0 035 $a(CKB)1000000000531235 035 $a(CONSER)sn 97039449 035 $a(DE-599)ZDB2059579-7 035 $a(EXLCZ)991000000000531235 100 $a19970915a199u9999 ua 101 0 $aeng 135 $aurcnu||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aCurrent problems in pharmacovigilance /$fCommittee on Safety of Medicines [and] Medicines Control Agency 210 $a[London $cThe Agency] 215 $a1 online resource 606 $aPharmacovigilance$vPeriodicals 606 $aDrug development$xStandards$vPeriodicals 606 $aDrugs$xQuality control$vPeriodicals 606 $aPharmaceutical Preparations$xadverse effects$vPeriodicals 615 0$aPharmacovigilance 615 0$aDrug development$xStandards 615 0$aDrugs$xQuality control 615 02$aPharmaceutical Preparations$xadverse effects 712 02$aGreat Britain.$bCommittee on Safety of Medicines. 712 02$aGreat Britain.$bMedicines Control Agency. 712 02$aGreat Britain.$bMedicines and Healthcare products Regulatory Agency. 906 $aJOURNAL 912 $a9910142821603321 920 $aexl_impl conversion 996 $aCurrent problems in pharmacovigilance$91965836 997 $aUNINA